Medication adherence in clinical trials is hard to verify, but new technologies are fixing that. Discover why traditional ...
Risk‑Based Monitoring (RBM) represents a proactive and systematic approach to clinical trial oversight, shifting away from ...
Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...
In this video interview, Sam Hinsley, statistics manager at Phastar, reflects on why she chose a career in clinical trials ...
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision ...
The U.S. Food and Drug Administration (FDA) announced a “real-time clinical trials” (RTCT) pilot program to permit agency reviewers to review ...
Q1-Q2 2026 European provider-user Black Book Research survey finds data valorisation, governed secondary use, cohort discovery, trial feasibility and RWE readiness now defining the next generation of ...
An official from the US Food and Drug Administration (FDA) on Monday presented three case studies demonstrating how sponsors effectively utilized real-world evidence (RWE) and real-world data (RWD) to ...
One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin ...
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results